Affinity, avidity, IgM, IgG, serological surveys and ‘antibody passports’
The University of Melbourne's Peter Doherty explains our immune response to COVID-19 and what 'antibody passports' look for after vaccination or infection.
Your protective Igs: The major focus of COVID-19 vaccines
As a scientists around the world continue to work on a COVID-19 vaccine – a University of Melbourne expert explains how and why they work at a cellular level.
How do we close the gaps in appropriate antibiotic use?
Melbourne University research shows that for rural hospitals to use better antibiotic prescribing practices, collaboration and workforce capacity are key.
The rise of the latest drug resistant superbug
Researchers at the Doherty Institute and the University of Melbourne have discovered a new superbug, already resistant to known antibiotics in parts of Europe.
Tuberculosis: Still a major killer
University of Melbourne researchers estimate for first time the burden of tuberculosis on adolescents and young adults, a group often ignored in disease control
HIV: Probing for a pathway to a cure
Clinical trial by Peter Doherty Institute at University of Melbourne suggests HIV can't replicate in people on antiretrovirals in key finding for cure efforts.
The science behind Victoria’s “flesh-eating bacteria”
As the Buruli ulcer cases linked to Mycobacterium ulcerans rises in Victoria, a University of Melbourne expert looks at the science behind the spread.
Stopping the flu virus at the nose
University of Melbourne researchers find flu-fighting cells in our noses that can act as "nasal border patrol' against the influenza virus.
The University of Melbourne is home to a team of expert flu-hunters, who track the virus's mutations and help update the annual vaccine.
Peter Doherty, 20 years after the Nobel Prize
Professor Peter Doherty shared medicine's Nobel Prize 20 years ago for his work fighting cancer. Today, this unconventional immunologist is still making waves.